Department of Internal Medicine, Intensive Care Unit, Medical University of Graz, Austria.
Department of Neurology, Medical University of Graz, Austria.
Vasa. 2022 Sep;51(5):315-319. doi: 10.1024/0301-1526/a001019. Epub 2022 Jul 8.
A 57-year-old male patient with a history of proximal deep vein thrombosis on vitamin K antagonist therapy, suffered a recent hypertensive intracranial hemorrhage without significant neurological deficit. Three weeks later he presented with bilateral central pulmonary embolism. He had witnessed cardiac arrest and was put on veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Endovascular thrombectomy with an Aspirex device led to a significant improvement of hemodynamics. VA-ECMO was terminated after one day, an IVC filter was inserted, and he was discharged from ICU after 15 days. In conclusion, VA-ECMO and endovascular therapy are rescue strategies in patients with contraindications for thrombolysis.
一位 57 岁男性患者,曾接受维生素 K 拮抗剂治疗近端深静脉血栓,近期发生无明显神经功能缺损的高血压性颅内出血。3 周后出现双侧中央性肺栓塞。他曾目睹过心脏骤停并接受了静脉-动脉体外膜肺氧合(VA-ECMO)治疗。使用 Aspirex 装置进行血管内血栓切除术导致血流动力学显著改善。VA-ECMO 在一天后停止,插入了下腔静脉滤器,患者在 15 天后从 ICU 出院。总之,VA-ECMO 和血管内治疗是溶栓禁忌证患者的抢救策略。